PubMed Health⌕ Search

Biomedical subjects

R Vaidya

Publications and source records attributed to R Vaidya.

21 records · Page 2Linked to original sources

Results of simultaneous open reduction and Salter innominate osteotomy for developmental dysplasia of the hip.

OBJECTIVES: To assess the results of simultaneous open reduction and Salter Innominate Osteotomy for developmental dysplasia of the hip in our context where there is a tendency for these cases to present late without having undergone any treatment previously. MATERIAL AND METHOD: We retrospectively reviewed the record files and radiographs of 22 dislocated hips of 20 patients managed with simultaneous open reduction and Salter osteotomy at Hospital and Rehabilitation Centre for Disabled Children from 1999 to 2001. Only eight patients with 9 hips with purely developmental dysplasia of hip aged one to seven years were included. The acetabular index on the initial and final radiographs was measured. The neck shaft angle was also measured. All radiographs were evaluated to determine the presence of avascular necrosis of the femoral head and position of the head after the operation. Clinical results were determined using modification of the McKay criteria (Pain, ROM, LLD, Containtment and Gait) . Follow-up ranged from a minimum of 1 year to a maximum of 5 years (average 3 years and 1 month). RESULTS: The results were excellent in 7 hips (77.77%) good in 1 hip (11.11%) and poor in 1 hip (11.11%) according to modified McKay criteria.. No complications related to infection, graft fracture, vascular or neural injury were encountered. CONCLUSION: When case selection for surgical treatment is appropriate, a reasonable excellent to good result can be expected even in cases such as ours which present late.

Child↗

Application of polytetrafluoroethylene (PTFE) membranes to control interference effects in a glucose biosensor.

The implantable feedback-controlled insulin delivery system provides the greatest potential for the control of certain types of diabetes mellitus. The development of an implantable glucose sensor is thus a prerequisite. A glucose biosensor using the enzyme glucose oxidase immobilized on fine carbon powder has been developed. Its in-vitro behavior is investigated in the presence of interfering substances commonly encountered in human blood and other body fluids. Here, in-vitro interference tests carried out on this sensor with polytetrafluoroethylene (PTFE) membranes are described. The authors used PTFE membranes (pore size 0.02 micron), some of which were coated with positively and negatively charged hydrogel layers. The sensors showed a stable and linear response to glucose concentrations > 300 mg/dL, in the presence of glucose alone in the phosphate buffer medium and in the presence of interferences. The interference effects of ascorbic acid, bilirubin, creatinine, L-cystine, glycine, uric acid, and urea on the amperometric signal of the sensor were studied. The PTFE membrane coated with the negatively charged hydrogel layer provided good protection for the enzyme electrode, especially in the presence of ionic interferants such as ascorbic acid and uric acid.

Biosensing Techniques↗